Nektar Therapeutics (NKTR) Announces Strategic Reprioritization and Cost Restructuring Plan Apr 17, 2023 05:01PM
Nektar Therapeutics Announces Strategic Reprioritization and Cost Restructuring Plan Apr 17, 2023 05:00PM
Nektar Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results Feb 28, 2023 05:15PM
Nektar Announces Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting Dec 12, 2022 10:05AM
Nektar Therapeutics (NKTR) and Collaborators Announces Publication of NKTR-255 Data Nov 9, 2022 09:01AM


Nov 9, 2022 09:00AM Nektar and Collaborators Announce Publication in Blood Advances of Preclinical Data Demonstrating NKTR-255, a Novel Polymer-conjugated Human IL-15, Improves Efficacy of CD19-targeted CAR-T Cell Immuno
Nov 3, 2022 04:15PM Nektar Therapeutics Reports Third Quarter 2022 Financial Results
Aug 4, 2022 04:15PM Nektar Therapeutics Reports Second Quarter 2022 Financial Results
Jul 1, 2022 06:31AM Nektar Therapeutics (NKTR) Appoints Jillian B. Thomsen as CFO
Jul 1, 2022 06:30AM Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer
May 5, 2022 04:15PM Nektar Therapeutics Reports First Quarter 2022 Financial Results
Apr 25, 2022 04:31PM Nektar Therapeutics (NKTR) is implementing a cost restructuring plan
Apr 25, 2022 04:30PM Nektar Therapeutics Announces Strategic Reorganization Plan and Corporate Outlook
Jul 30, 2014 03:07PM Trading Radar for 07/31: Exxon (XOM) , Tesla (TSLA), LinkedIn (LNKD), Expedia (EXPE), McKesson (MCK) Report
Nov 1, 2011 06:09PM Trading Radar for 11/02: MasterCard (MA), Level 3 (LVLT), Clearwire (CLWR), MEMC Electronic Materials (WFR), Avis Budget (CAR) Report
Nov 3, 2009 01:42PM Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report